The subsequent activation of intracellular receptor soluble guanylyl cyclase (sGC), leads to the activation of the NO-cGMP signaling pathway, present in neurons of the spinal cord implicated in CS, secondary hyperalgesia, and modulation of ion channels. This evidence concerns the gene SGCB and Cowden syndrome 1.